Clinical features of the control and type 2 diabetic subjects
| Control subjects | Type 2 diabetic subjects | |
|---|---|---|
| n (M/F) | 200 (108/92) | 195 (95/100) |
| Age (years) | 54.3 ± 8.1 | 60.0 ± 11.6 |
| Age of onset (years) | 48.4 ± 12.3 | |
| Duration of diabetes (years) | 11.7 ± 9.1 | |
| Height (cm) | 161.5 ± 8.1 | 157.9 ± 8.9 |
| BW (kg) | 60.3 ± 10.0 | 58.4 ± 12.0 |
| Max BW (kg) | 68.4 ± 14.7 | |
| δBW (kg) | 9.9 ± 6.8 | |
| Age of max BW (years) | 44.3 ± 14.5 | |
| BMI (kg/m2) | 23.0 ± 2.8 | 23.4 ± 3.7 |
| Max BMI (kg/m2) | 27.3 ± 4.7 | |
| δBMI (kg/m2) | 4.0 ± 2.7 | |
| HbA1c (%) | 4.8 ± 0.3 | 7.7 ± 1.7 |
| Treatment (diet/OHA/insulin) | 46/104/45 |
Data are means ± SD. BW, body weight; Max BW, maximum body weight; δBW, Max BW − BW; δBMI, Max BMI − BMI; OHA, oral hypoglycemic agents.